undamentalytics Newsletter
Sign in

Steris cash flow statement

In fiscal 2026, Steris's operations generated $1.34bn of cash; it spent $369m on capital projects, leaving free cash flow of $972m. It returned $242m in dividends and $236m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Mar 20172018Mar 20182019Mar 20192020Mar 20202021Mar 20212022Mar 20222023Mar 20232024Mar 20242025Mar 20252026Mar 2026LTMJun 2026
Cash from operations4244585405916906857579731,1481,3411,289
Depreciation and amortisation188178226197219553553565476487491
Stock-based pay1922242426583957576263
Capital spending173165190215239288362360370369363
Free cash flow251292350376450397395613778972926
Free cash flow after stock pay232270326352424340356557721911863
Dividends paid93103113123134163183201220242247
Share buybacks98658151155630912211236340
Shares issued500————————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: RMD vs STEEW vs STEBLCO vs STE

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Steris's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Steris.